Hundreds of children in England receive GLP-1 drugs for obesity, some under age 12

A Guardian investigation revealed that hundreds of children in England are prescribed GLP-1 drugs such as Wegovy and Mounjaro, originally used to treat type 2 diabetes and now popular as weight-loss treatments. Patients include children under age 12. Experts emphasize the need for specialist medical supervision and long-term monitoring when these drugs are used in young children.